High-resolution magnetic resonance imaging sinc-interpolation-based subvoxel registration and semi-automated quantitative lateral ventricular morphology employing threshold computation and binary image creation in the study of fatty acid interventions in schizophrenia, depression, chronic fatigue syndrome and Huntington's disease

References

• Bydder GM, Hajnal JV. Registration and subtraction of serial MRI—Part 2: Image interpretation. Advanced MR Imaging Techniques, WG Bradley, GM Bydder. Martin Dunitz Freeman, London 1997
   Google Scholar
• Gonzalez RC, Woods RE. Digital Image Processing. Addison-Wesley, New York 1992
   Google Scholar
• Hajnal JV, Saeed N, Soar EJ, Oatridge A, Young IR, Bydder GM. A registration and interpolation procedure for subvoxel matching of serially acquired MR images. Journal of Computer Assisted Tomography 1995; 19: 289–296
   PubMedGoogle Scholar
• Hajnal JV, Bydder GM. Registration and subtraction of serial MRI—Part 1: Technique. Advanced MR Imaging Techniques, WG Bradley, GM Bydder. Martin Dunitz Freeman, London 1997
   Google Scholar
• Herman GT, Liu HK. Dynamic boundary surface detection. Computer Graphics Image Processing 1978; 7: 130–138
   Google Scholar
• Jain AK. Fundamentals of Digital Image Processing. Prentice Hall, Englewood Cliffs 1989
   Google Scholar
• Marshall S, Saeed N, Young IH, Durrani TS, Dalton B, DuBoulay G. System for automatic patient realignment of the head in magnetic resonance imaging. IEEE Proceedings, Artificial Intelligence in Signal Processing 1990; 137: 319–330
   Google Scholar
• Puri BK. A possible role for fatty acid treatment in paediatric depression. Phospholipid Spectrum Disorders in Psychiatry and Neurology, M Peet, I Glen, DF Horrobin. Marius Press, Carnforth 2003a; 543–548
   Google Scholar
• Puri BK. A randomised trial of ethyl eicosapentaenoate in patients with end-stage Huntington's disease. Phospholipid Spectrum Disorders in Psychiatry and Neurology, M Peet, I Glen, DF Horrobin. Marius Press, Carnforth 2003b; 575–579
   Google Scholar
• Puri BK. Monomodal rigid-body registration and applications to the investigation of the effects of eicosapentaenoic acid intervention in neuropsychiatric disorders. Prostaglandins, Leukotrienes and Essential Fatty Acids 2004a; 71: 177–179
   PubMedGoogle Scholar
• Puri BK. The use of eicosapentaenoic acid in the treatment of chronic fatigue syndrome. Prostaglandins, Leukotrienes and Essential Fatty Acids 2004b; 70: 399–401
   PubMed Web of Science ®Google Scholar
• Puri BK. Chronic fatigue syndrome. Hammersmith Press, London 2005
   Google Scholar
• Puri BK, Richardson AJ. Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid. Archives of General Psychiatry 1998; 55: 188–189
   PubMed Web of Science ®Google Scholar
• Puri BK, Richardson AJ. Long-term follow-up of a single patient with schizophrenia treated with ethyl-EPA alone. Phospholipid Spectrum Disorders in Psychiatry and Neurology, M Peet, I Glen, DF Horrobin. Marius Press, Carnforth 2003; 377–389
   Google Scholar
• Puri BK, Bydder GM, Counsell SJ, et al. MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment. NeuroReport 2002b; 13: 123–126
   PubMed Web of Science ®Google Scholar
• Puri BK, Counsell SJ, Hamilton G, Richardson AJ, Horrobin DF. Eicosapentaenoic acid treatment in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover. International Journal of Clinical Practice 2001; 55: 560–563
   PubMed Web of Science ®Google Scholar
• Puri BK, Counsell SJ, Richardson AJ, Horrobin DF. Eicosapentaenoic acid in treatment-resistant depression. Archives of General Psychiatry 2002a; 59: 91–92
   PubMedGoogle Scholar
• Puri BK, Holmes J, Hamilton G. Eicosapentaenoic acid-rich essential fatty acid supplementation in chronic fatigue syndrome associated with symptom remission and structural brain changes. International Journal of Clinical Practice 2004; 58: 297–299
   PubMedGoogle Scholar
• Puri BK, Richardson AJ, Horrobin DF, et al. Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes. International Journal of Clinical Practice 2000; 54: 57–63
   PubMed Web of Science ®Google Scholar
• Saeed N. Application of digital image processing in magnetic resonance scanning. 1990, PhD thesis, Signal Processing Division. Glasgow: University of Strathclyde
   Google Scholar
• Saeed N, Puri BK, Oatridge A, Hajnal JV, Young IR. Two methods for semi-automated quantification of changes in ventricular volume and their use in schizophrenia. Magnetic Resonance Imaging 1998; 16: 1237–1247
   PubMedGoogle Scholar
• Vaddadi KS. Essential fatty acids in the treatment of Huntington's disease. Phospholipid Spectrum Disorders in Psychiatry and Neurology, M Peet, I Glen, DF Horrobin. Marius Press, Carnforth 2003; 565–574
   Google Scholar